We are live on
!
Find out more
GCM
Graham Capital Management Portfolio holdings
AUM
$4.14B
1-Year Est. Return
17.82%
This Fund
S&P 500
This Quarter
Est. Return
+4.11%
1 Year Est. Return
+17.82%
3 Year Est. Return
+41.13%
5 Year Est. Return
+43.39%
10 Year Est. Return
+274.46%
AUM
$6.66B
AUM Growth
+$848M
(+15%)
Cap. Flow
-$1.13B
Cap. Flow
% of AUM
-16.93%
Top 10 Holdings %
Top 10 Hldgs %
57.62%
Holding
1,535
New
470
Increased
412
Reduced
291
Closed
336
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$35.5M |
| 2 |
PepsiCo
PEP
|
+$19.5M |
| 3 |
Johnson & Johnson
JNJ
|
+$17.3M |
| 4 |
Amazon
AMZN
|
+$15.8M |
| 5 |
S&P Global
SPGI
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$69.8M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$21.3M |
| 3 |
Microsoft
MSFT
|
+$21.2M |
| 4 |
Walmart Inc
WMT
|
+$17.1M |
| 5 |
Citigroup
C
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.84% |
| 2 | Industrials | 4.12% |
| 3 | Financials | 3.46% |
| 4 | Consumer Discretionary | 3.25% |
| 5 | Healthcare | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
AXT Inc
AXTI
$5.8B
| $108K | ﹤0.01% |
49,947
+24,534
| +97% | +$55.7K |
|
1127
Tango Therapeutics
TNGX
$4.41B
| $108K | ﹤0.01% |
+34,804
| New | +$162K |
|
1128
Virco
VIRC
$96.3M
| $107K | ﹤0.01% |
+10,476
| New | +$147K |
|
1129
AngioDynamics
ANGO
$649M
| $106K | ﹤0.01% |
+11,531
| New | +$84.8K |
|
1130
Coherus Oncology
CHRS
$196M
| $105K | ﹤0.01% |
76,300
+7,649
| +11% | +$8.58K |
|
1131
Holley
HLLY
$384M
| $105K | ﹤0.01% |
+34,789
| New | +$97.4K |
|
|
TPIC
1132
DELISTED
TPI Composites
TPIC
| $105K | ﹤0.01% |
+55,333
| New | +$154K |
|
1133
Rackspace Technology
RXT
$1.24B
| $104K | ﹤0.01% |
+47,272
| New | +$119K |
|
1134
Hyliion Holdings
HYLN
$690M
| $104K | ﹤0.01% |
+39,818
| New | +$111K |
|
1135
Aurinia Pharmaceuticals
AUPH
$2.11B
| $102K | ﹤0.01% |
+11,409
| New | +$93.1K |
|
1136
VTEX
VTEX
$713M
| $101K | ﹤0.01% |
+17,202
| New | +$113K |
|
1137
Kodak
KODK
$983M
| $99.7K | ﹤0.01% |
15,175
-6,143
| -29% | -$34.9K |
|
1138
Nomura Holdings
NMR
$29.1B
| $99.2K | ﹤0.01% |
17,136
-348
| -2% | -$1.98K |
|
1139
Corvus Pharmaceuticals
CRVS
$1.17B
| $97.9K | ﹤0.01% |
+18,305
| New | +$137K |
|
1140
MaxCyte
MXCT
$126M
| $95.9K | ﹤0.01% |
+23,047
| New | +$87.1K |
|
1141
Future Fuel
FF
$223M
| $95.4K | ﹤0.01% |
+18,026
| New | +$101K |
|
|
TSVT
1142
DELISTED
2seventy bio
TSVT
| $95.3K | ﹤0.01% |
32,426
+18,357
| +130% | +$75.3K |
|
|
SGMO
1143
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $95K | ﹤0.01% |
93,175
-62,967
| -40% | -$115K |
|
|
BHR
1144
Braemar Hotels & Resorts
BHR
$142M
| $91.8K | ﹤0.01% |
30,606
+10,936
| +56% | +$35.4K |
|
|
GPMT
1145
Granite Point Mortgage Trust
GPMT
$61.2M
| $91.7K | ﹤0.01% |
32,850
+4,015
| +14% | +$12.6K |
|
1146
Nektar Therapeutics
NKTR
$2.58B
| $90.1K | ﹤0.01% |
6,461
+5,191
| +409% | +$91.5K |
|
1147
Allogene Therapeutics
ALLO
$694M
| $88.9K | ﹤0.01% |
+41,737
| New | +$103K |
|
|
KALV
1148
DELISTED
KalVista Pharmaceuticals
KALV
| $88.8K | ﹤0.01% |
+10,479
| New | +$109K |
|
|
ITOS
1149
DELISTED
iTeos Therapeutics
ITOS
| $85.4K | ﹤0.01% |
+11,126
| New | +$95.6K |
|
1150
Lucid Motors
LCID
$2.77B
| $81.9K | ﹤0.01% |
+2,712
| New | +$70.6K |
|
Similar funds
SP
BOK
ZP
SHCM
AP
BHC
BG
MGP
Graham Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Graham Capital Management held 1,535 positions worth $6.66B, up 15% from $5.81B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Graham Capital Management withdrew a net $1.13B in Q4 2024, closing 336 positions and reducing 291 holdings. Its most notable exit was VanEck Gold Miners ETF, an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.7% a quarter earlier, followed by Industrials and Financials.
Against the trend, Graham Capital Management opened a new position in Strategy Inc worth $34.1M.
- Graham Capital Management's largest Q4 2024 buy was Strategy Inc: 117,912 shares worth $34.1M.
- Graham Capital Management added most to Amazon in Q4 2024, an estimated $15.8M increase.
- Graham Capital Management's biggest Q4 2024 reduction was iShares Bitcoin Trust, cutting an estimated $69.8M.
- Graham Capital Management fully exited VanEck Gold Miners ETF in Q4 2024, selling an estimated $21.3M.
- Graham Capital Management's ten largest holdings make up 58% of its $6.66B portfolio in Q4 2024.
- Graham Capital Management opened 470 new positions and closed 336 in Q4 2024.
- Graham Capital Management's portfolio value rose 15% quarter-over-quarter to $6.66B.
Based on Graham Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.